

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transcytosis (GO:0045056) | 8.77775822 |
| 2 | intestinal absorption (GO:0050892) | 8.66897679 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 7.58605618 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 7.58605618 |
| 5 | cholesterol catabolic process (GO:0006707) | 7.32050472 |
| 6 | sterol catabolic process (GO:0016127) | 7.32050472 |
| 7 | cobalamin metabolic process (GO:0009235) | 6.96450978 |
| 8 | peptidyl-proline hydroxylation (GO:0019511) | 6.53773135 |
| 9 | negative regulation of digestive system process (GO:0060457) | 6.18123025 |
| 10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.75154530 |
| 11 | membrane lipid catabolic process (GO:0046466) | 5.69472561 |
| 12 | regulation of phospholipase A2 activity (GO:0032429) | 5.56266832 |
| 13 | glycolipid catabolic process (GO:0019377) | 5.49875851 |
| 14 | positive regulation of nuclease activity (GO:0032075) | 5.49577365 |
| 15 | ceramide catabolic process (GO:0046514) | 5.28418969 |
| 16 | valine metabolic process (GO:0006573) | 5.16641474 |
| 17 | protein hydroxylation (GO:0018126) | 5.16014398 |
| 18 | regulation of nuclease activity (GO:0032069) | 4.99932780 |
| 19 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.95203884 |
| 20 | cysteine metabolic process (GO:0006534) | 4.94856689 |
| 21 | protein maturation by protein folding (GO:0022417) | 4.81084108 |
| 22 | cellular response to unfolded protein (GO:0034620) | 4.78654897 |
| 23 | branched-chain amino acid catabolic process (GO:0009083) | 4.70415438 |
| 24 | response to endoplasmic reticulum stress (GO:0034976) | 4.69963500 |
| 25 | COPII vesicle coating (GO:0048208) | 4.69937191 |
| 26 | endocrine pancreas development (GO:0031018) | 4.63865628 |
| 27 | ER-nucleus signaling pathway (GO:0006984) | 4.59846921 |
| 28 | cellular response to topologically incorrect protein (GO:0035967) | 4.51033164 |
| 29 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.43992551 |
| 30 | branched-chain amino acid metabolic process (GO:0009081) | 4.36447010 |
| 31 | cellular modified amino acid catabolic process (GO:0042219) | 4.31622582 |
| 32 | proline biosynthetic process (GO:0006561) | 4.28791376 |
| 33 | ER overload response (GO:0006983) | 4.26332424 |
| 34 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.14224350 |
| 35 | intestinal epithelial cell development (GO:0060576) | 4.10502275 |
| 36 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.05879416 |
| 37 | mitochondrial calcium ion transport (GO:0006851) | 4.03846114 |
| 38 | maintenance of protein localization in organelle (GO:0072595) | 3.96006451 |
| 39 | 4-hydroxyproline metabolic process (GO:0019471) | 3.87367894 |
| 40 | zinc ion transport (GO:0006829) | 3.85812284 |
| 41 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.78112480 |
| 42 | signal peptide processing (GO:0006465) | 3.77452041 |
| 43 | response to unfolded protein (GO:0006986) | 3.75943147 |
| 44 | homocysteine metabolic process (GO:0050667) | 3.75916956 |
| 45 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.73488477 |
| 46 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.71496333 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.67995809 |
| 48 | steroid catabolic process (GO:0006706) | 3.65577709 |
| 49 | response to topologically incorrect protein (GO:0035966) | 3.59363996 |
| 50 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.57860093 |
| 51 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.55019475 |
| 52 | glutamine metabolic process (GO:0006541) | 3.53340571 |
| 53 | vesicle coating (GO:0006901) | 3.49836204 |
| 54 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.47249016 |
| 55 | peptidyl-asparagine modification (GO:0018196) | 3.46817888 |
| 56 | cholesterol transport (GO:0030301) | 3.38005896 |
| 57 | sterol transport (GO:0015918) | 3.38005896 |
| 58 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.36594896 |
| 59 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.33629102 |
| 60 | sphingolipid catabolic process (GO:0030149) | 3.31890266 |
| 61 | membrane repolarization during action potential (GO:0086011) | 3.30292675 |
| 62 | digestive system process (GO:0022600) | 3.28979856 |
| 63 | Golgi organization (GO:0007030) | 3.27008001 |
| 64 | leukotriene biosynthetic process (GO:0019370) | 3.23497705 |
| 65 | protein N-linked glycosylation (GO:0006487) | 3.15785816 |
| 66 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.14841424 |
| 67 | mitochondrion distribution (GO:0048311) | 3.14216985 |
| 68 | aspartate family amino acid catabolic process (GO:0009068) | 3.07947486 |
| 69 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.99578599 |
| 70 | antibacterial humoral response (GO:0019731) | 2.97844191 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 2.97514294 |
| 72 | creatine metabolic process (GO:0006600) | 2.94334358 |
| 73 | neutrophil mediated immunity (GO:0002446) | 2.93323542 |
| 74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.88276817 |
| 75 | L-phenylalanine catabolic process (GO:0006559) | 2.87341002 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.87341002 |
| 77 | regulation of digestive system process (GO:0044058) | 2.85155280 |
| 78 | biotin metabolic process (GO:0006768) | 2.80794678 |
| 79 | cell redox homeostasis (GO:0045454) | 2.78960018 |
| 80 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.77167898 |
| 81 | proline metabolic process (GO:0006560) | 2.76118367 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73693542 |
| 83 | antimicrobial humoral response (GO:0019730) | 2.73436367 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71636826 |
| 85 | pancreas development (GO:0031016) | 2.71423523 |
| 86 | myeloid leukocyte mediated immunity (GO:0002444) | 2.70569208 |
| 87 | positive regulation of heat generation (GO:0031652) | 2.70089925 |
| 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.68551049 |
| 89 | axoneme assembly (GO:0035082) | 2.67390828 |
| 90 | one-carbon metabolic process (GO:0006730) | 2.66171502 |
| 91 | establishment of protein localization to Golgi (GO:0072600) | 2.65385334 |
| 92 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.64600179 |
| 93 | L-phenylalanine metabolic process (GO:0006558) | 2.64600179 |
| 94 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.63285609 |
| 95 | cellular protein catabolic process (GO:0044257) | 2.62286801 |
| 96 | negative regulation of cell killing (GO:0031342) | 2.62004193 |
| 97 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62004193 |
| 98 | regulation of germinal center formation (GO:0002634) | 2.60990908 |
| 99 | type B pancreatic cell development (GO:0003323) | 2.59895503 |
| 100 | polarized epithelial cell differentiation (GO:0030859) | 2.59623258 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.58849902 |
| 102 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.57473190 |
| 103 | glycine transport (GO:0015816) | 2.56730291 |
| 104 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.55419876 |
| 105 | regulation of fever generation (GO:0031620) | 2.55141101 |
| 106 | regulation of relaxation of muscle (GO:1901077) | 2.54933199 |
| 107 | glandular epithelial cell differentiation (GO:0002067) | 2.54022562 |
| 108 | cilium movement (GO:0003341) | 2.53478201 |
| 109 | microglial cell activation (GO:0001774) | 2.52912473 |
| 110 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52824478 |
| 111 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.51917709 |
| 112 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.51089439 |
| 113 | endoplasmic reticulum organization (GO:0007029) | 2.49029358 |
| 114 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.48712809 |
| 115 | negative regulation of B cell mediated immunity (GO:0002713) | 2.48712809 |
| 116 | behavioral response to ethanol (GO:0048149) | 2.48286327 |
| 117 | negative regulation of epidermis development (GO:0045683) | 2.47307176 |
| 118 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.47268783 |
| 119 | activated T cell proliferation (GO:0050798) | 2.45219352 |
| 120 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45006958 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44978189 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.44859482 |
| 123 | fucose catabolic process (GO:0019317) | 2.44456523 |
| 124 | L-fucose metabolic process (GO:0042354) | 2.44456523 |
| 125 | L-fucose catabolic process (GO:0042355) | 2.44456523 |
| 126 | protein targeting to Golgi (GO:0000042) | 2.42960806 |
| 127 | epithelial cilium movement (GO:0003351) | 2.42633164 |
| 128 | macroautophagy (GO:0016236) | 2.40533609 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.40288034 |
| 130 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.39797637 |
| 131 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.39687629 |
| 132 | regulation of skeletal muscle contraction (GO:0014819) | 2.38284522 |
| 133 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.37192912 |
| 134 | regulation of protein glycosylation (GO:0060049) | 2.37100648 |
| 135 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.35499974 |
| 136 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.35499974 |
| 137 | neuronal action potential propagation (GO:0019227) | 2.31554876 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.29831527 |
| 139 | tryptophan catabolic process (GO:0006569) | 2.29264775 |
| 140 | indole-containing compound catabolic process (GO:0042436) | 2.29264775 |
| 141 | indolalkylamine catabolic process (GO:0046218) | 2.29264775 |
| 142 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.26375136 |
| 143 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.25054369 |
| 144 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.24743140 |
| 145 | cellular extravasation (GO:0045123) | 2.22806097 |
| 146 | neuronal action potential (GO:0019228) | 2.22068405 |
| 147 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.19529678 |
| 148 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.18788570 |
| 149 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.18141807 |
| 150 | one-carbon compound transport (GO:0019755) | 2.16886795 |
| 151 | protein localization to Golgi apparatus (GO:0034067) | 2.16598867 |
| 152 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.15493278 |
| 153 | regulation of triglyceride catabolic process (GO:0010896) | 2.13599805 |
| 154 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.13524180 |
| 155 | cAMP catabolic process (GO:0006198) | 2.12254131 |
| 156 | indolalkylamine metabolic process (GO:0006586) | 2.11238783 |
| 157 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.08927537 |
| 158 | protein K11-linked deubiquitination (GO:0035871) | 2.08268911 |
| 159 | negative regulation of adaptive immune response (GO:0002820) | 2.08167190 |
| 160 | interkinetic nuclear migration (GO:0022027) | 2.06525150 |
| 161 | cellular ketone body metabolic process (GO:0046950) | 2.05580520 |
| 162 | regulation of memory T cell differentiation (GO:0043380) | 2.05289411 |
| 163 | drug catabolic process (GO:0042737) | 2.04669720 |
| 164 | detection of light stimulus involved in visual perception (GO:0050908) | 2.04491642 |
| 165 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.04491642 |
| 166 | reactive oxygen species biosynthetic process (GO:1903409) | 2.03163780 |
| 167 | regulation of sarcomere organization (GO:0060297) | 2.02667373 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.02102885 |
| 169 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.01381776 |
| 170 | negative regulation of protein oligomerization (GO:0032460) | 2.00383290 |
| 171 | intestinal cholesterol absorption (GO:0030299) | 18.9226530 |
| 172 | exocrine pancreas development (GO:0031017) | 13.3456397 |
| 173 | * digestion (GO:0007586) | 11.9362099 |
| 174 | protein retention in ER lumen (GO:0006621) | 11.4937468 |
| 175 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 10.9468426 |
| 176 | behavioral response to nicotine (GO:0035095) | 1.99409214 |
| 177 | regulation of cell communication by electrical coupling (GO:0010649) | 1.98510878 |
| 178 | opioid receptor signaling pathway (GO:0038003) | 1.96326813 |
| 179 | neural tube formation (GO:0001841) | 1.96141992 |
| 180 | cyclic nucleotide catabolic process (GO:0009214) | 1.96083668 |
| 181 | negative regulation of T cell mediated immunity (GO:0002710) | 1.95553429 |
| 182 | relaxation of cardiac muscle (GO:0055119) | 1.94300970 |
| 183 | adaptation of signaling pathway (GO:0023058) | 1.93758423 |
| 184 | positive regulation of cation channel activity (GO:2001259) | 1.93168277 |
| 185 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 1.92287596 |
| 186 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 1.91355287 |
| 187 | axonemal dynein complex assembly (GO:0070286) | 1.91229697 |
| 188 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.90639135 |
| 189 | monoubiquitinated protein deubiquitination (GO:0035520) | 1.89382447 |
| 190 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 1.88810049 |
| 191 | muscle hypertrophy (GO:0014896) | 1.88665204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.20977862 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.27478361 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.30209704 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.76298707 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.31033028 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.09823226 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.77454389 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77398271 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65599500 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.62928799 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62504202 |
| 12 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.60911051 |
| 13 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.53948083 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.35604137 |
| 15 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.22631519 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.17560864 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03515708 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.92812533 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89736868 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86992626 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85490916 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85341845 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83438261 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83320200 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80902065 |
| 26 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80410297 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80282307 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78505236 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76294540 |
| 30 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.72811716 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72740717 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68793305 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68507992 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67841333 |
| 35 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.65959138 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62255778 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59733695 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59451385 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56506993 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55732396 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.54528876 |
| 42 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54322095 |
| 43 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.54285067 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54254453 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52433553 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50290447 |
| 47 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.49455870 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49101845 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.46441617 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46169537 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.45939985 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45469666 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45005195 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43347285 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42175693 |
| 56 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.40982741 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40332270 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40023613 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38290676 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38111509 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37982023 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36830278 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36656356 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35584276 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34946022 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32891637 |
| 67 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.32268166 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31138613 |
| 69 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29392866 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26863704 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26616372 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26051080 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25606069 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25240110 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24520037 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23671609 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23507432 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23324268 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23299926 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23280923 |
| 81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23280923 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23276192 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23119052 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22656220 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22401084 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22401084 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22309845 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21386277 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20924576 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20006207 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19733120 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19160845 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19036190 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17878866 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17619225 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17456670 |
| 97 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16889326 |
| 98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16644395 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16626954 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16311634 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16202620 |
| 102 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.15279696 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15066573 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15036003 |
| 105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15036003 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14372810 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12455800 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11602381 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11382901 |
| 110 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10827566 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10827566 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10636772 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09602911 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08677795 |
| 115 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08381204 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07585529 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07222848 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07053817 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06946560 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06940997 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06576154 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06552363 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06243415 |
| 124 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05463126 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05429608 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05197806 |
| 127 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.04805216 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04770169 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04741735 |
| 130 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04733699 |
| 131 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04711286 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02874180 |
| 133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02767670 |
| 134 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02326286 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02270141 |
| 136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01131585 |
| 137 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01104014 |
| 138 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00203796 |
| 139 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00069627 |
| 140 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99900222 |
| 141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99519841 |
| 142 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99488471 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99250106 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99134680 |
| 145 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98715090 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98553255 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98089753 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97965494 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97516250 |
| 150 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97289011 |
| 151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96936992 |
| 152 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96931076 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96905994 |
| 154 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96859535 |
| 155 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96782554 |
| 156 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96744899 |
| 157 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96678181 |
| 158 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96629935 |
| 159 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96187512 |
| 160 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96187512 |
| 161 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96187512 |
| 162 | P68_20966046_ChIP-Seq_HELA_Human | 0.94829660 |
| 163 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93713728 |
| 164 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92976188 |
| 165 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92906303 |
| 166 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92229034 |
| 167 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.92201285 |
| 168 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91776345 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91649345 |
| 170 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91384979 |
| 171 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90859568 |
| 172 | TBL1_22424771_ChIP-Seq_293T_Human | 0.90744793 |
| 173 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90527113 |
| 174 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90169390 |
| 175 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90001201 |
| 176 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89856113 |
| 177 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89561684 |
| 178 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89261572 |
| 179 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88867837 |
| 180 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88389332 |
| 181 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88213801 |
| 182 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.86680469 |
| 183 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86671528 |
| 184 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85253096 |
| 185 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83873508 |
| 186 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82411425 |
| 187 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81159210 |
| 188 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.80698511 |
| 189 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80653024 |
| 190 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80143879 |
| 191 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80105568 |
| 192 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79421832 |
| 193 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.78957581 |
| 194 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77864840 |
| 195 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.77828986 |
| 196 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76008834 |
| 197 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75816587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 9.18128424 |
| 2 | MP0001666_abnormal_nutrient_absorption | 8.68396272 |
| 3 | MP0005365_abnormal_bile_salt | 6.34372199 |
| 4 | MP0005220_abnormal_exocrine_pancreas | 5.53143583 |
| 5 | MP0003868_abnormal_feces_composition | 5.43569758 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 4.72268892 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.61277554 |
| 8 | MP0002693_abnormal_pancreas_physiology | 3.01773272 |
| 9 | MP0003646_muscle_fatigue | 2.72866395 |
| 10 | MP0003959_abnormal_lean_body | 2.69763069 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.57424943 |
| 12 | MP0001944_abnormal_pancreas_morphology | 2.36444630 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.26249908 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.15551229 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.15293875 |
| 16 | MP0001664_abnormal_digestion | 2.11830281 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.05592115 |
| 18 | MP0003724_increased_susceptibility_to | 2.04681843 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.03293599 |
| 20 | MP0003283_abnormal_digestive_organ | 1.87082580 |
| 21 | MP0008004_abnormal_stomach_pH | 1.83813700 |
| 22 | MP0003252_abnormal_bile_duct | 1.82751117 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.80462495 |
| 24 | MP0003880_abnormal_central_pattern | 1.73455626 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.70646068 |
| 26 | MP0005448_abnormal_energy_balance | 1.70637143 |
| 27 | MP0009745_abnormal_behavioral_response | 1.65531154 |
| 28 | MP0005670_abnormal_white_adipose | 1.58222624 |
| 29 | MP0002272_abnormal_nervous_system | 1.52182528 |
| 30 | MP0001486_abnormal_startle_reflex | 1.51980069 |
| 31 | MP0004484_altered_response_of | 1.51307294 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.47611575 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.45993240 |
| 34 | MP0002928_abnormal_bile_duct | 1.43522713 |
| 35 | MP0004885_abnormal_endolymph | 1.42634332 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.42568852 |
| 37 | MP0003879_abnormal_hair_cell | 1.41474294 |
| 38 | MP0002064_seizures | 1.39266502 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.39003130 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.37196945 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.36250797 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.32119984 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.29917259 |
| 44 | MP0002078_abnormal_glucose_homeostasis | 1.27312606 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.26179910 |
| 46 | MP0004233_abnormal_muscle_weight | 1.26001427 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.24966671 |
| 48 | MP0003633_abnormal_nervous_system | 1.24485692 |
| 49 | MP0003787_abnormal_imprinting | 1.23245579 |
| 50 | MP0009046_muscle_twitch | 1.22630558 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.21492118 |
| 52 | MP0001835_abnormal_antigen_presentation | 1.20775565 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.18194739 |
| 54 | MP0008872_abnormal_physiological_respon | 1.15665526 |
| 55 | MP0005310_abnormal_salivary_gland | 1.14762496 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.13416777 |
| 57 | MP0005387_immune_system_phenotype | 1.13311058 |
| 58 | MP0001790_abnormal_immune_system | 1.13311058 |
| 59 | MP0006054_spinal_hemorrhage | 1.13104481 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.11823521 |
| 61 | MP0001800_abnormal_humoral_immune | 1.11017216 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.09158110 |
| 63 | MP0001970_abnormal_pain_threshold | 1.08812177 |
| 64 | MP0002063_abnormal_learning/memory/cond | 1.08076189 |
| 65 | MP0002132_abnormal_respiratory_system | 1.07094471 |
| 66 | MP0004142_abnormal_muscle_tone | 1.06672758 |
| 67 | MP0006082_CNS_inflammation | 1.03760535 |
| 68 | MP0009764_decreased_sensitivity_to | 1.03755869 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.03510832 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.01907496 |
| 71 | MP0004215_abnormal_myocardial_fiber | 1.01077845 |
| 72 | MP0002733_abnormal_thermal_nociception | 0.99038045 |
| 73 | MP0005165_increased_susceptibility_to | 0.99006361 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.98987677 |
| 75 | MP0000470_abnormal_stomach_morphology | 0.98476295 |
| 76 | MP0002971_abnormal_brown_adipose | 0.95209692 |
| 77 | MP0003690_abnormal_glial_cell | 0.94725358 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 0.94534982 |
| 79 | MP0002127_abnormal_cardiovascular_syste | 0.94156778 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.94007291 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.93856935 |
| 82 | MP0004084_abnormal_cardiac_muscle | 0.93539627 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.93160689 |
| 84 | MP0006276_abnormal_autonomic_nervous | 0.92094017 |
| 85 | MP0004924_abnormal_behavior | 0.91628160 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.91628160 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.91397467 |
| 88 | MP0000613_abnormal_salivary_gland | 0.91201192 |
| 89 | MP0004043_abnormal_pH_regulation | 0.90532663 |
| 90 | MP0001984_abnormal_olfaction | 0.90491194 |
| 91 | MP0002419_abnormal_innate_immunity | 0.89993903 |
| 92 | MP0008569_lethality_at_weaning | 0.89700085 |
| 93 | MP0003953_abnormal_hormone_level | 0.88904039 |
| 94 | MP0003045_fibrosis | 0.88632649 |
| 95 | MP0005332_abnormal_amino_acid | 0.88006537 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.87949507 |
| 97 | MP0002229_neurodegeneration | 0.87707336 |
| 98 | MP0005671_abnormal_response_to | 0.86092987 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85836521 |
| 100 | MP0002723_abnormal_immune_serum | 0.85450641 |
| 101 | MP0004270_analgesia | 0.85142419 |
| 102 | MP0002102_abnormal_ear_morphology | 0.83111291 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.83107591 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.83046193 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.82243401 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.82078551 |
| 107 | MP0005535_abnormal_body_temperature | 0.81897830 |
| 108 | MP0002822_catalepsy | 0.81682594 |
| 109 | MP0003866_abnormal_defecation | 0.80879189 |
| 110 | MP0001819_abnormal_immune_cell | 0.80874170 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.80619121 |
| 112 | MP0005620_abnormal_muscle_contractility | 0.80569234 |
| 113 | MP0000749_muscle_degeneration | 0.80154123 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.79458798 |
| 115 | MP0005408_hypopigmentation | 0.78661761 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.77701268 |
| 117 | MP0003195_calcinosis | 0.77460839 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.76547267 |
| 119 | MP0005499_abnormal_olfactory_system | 0.76547267 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.76532797 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.72720348 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.66639257 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.63379614 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.62010584 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.61855736 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.61320437 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.60153951 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.57339977 |
| 129 | MP0005187_abnormal_penis_morphology | 0.56050754 |
| 130 | MP0000598_abnormal_liver_morphology | 0.55879612 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.54763460 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.53922012 |
| 133 | MP0003806_abnormal_nucleotide_metabolis | 0.52927724 |
| 134 | MP0003122_maternal_imprinting | 0.52448885 |
| 135 | MP0009703_decreased_birth_body | 0.52351940 |
| 136 | MP0000609_abnormal_liver_physiology | 0.50027975 |
| 137 | MP0001731_abnormal_postnatal_growth | 0.46048383 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.44817525 |
| 139 | MP0000490_abnormal_crypts_of | 0.44264699 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.42686122 |
| 141 | MP0003119_abnormal_digestive_system | 0.40709389 |
| 142 | MP0002060_abnormal_skin_morphology | 0.38821066 |
| 143 | MP0003172_abnormal_lysosome_physiology | 0.37107261 |
| 144 | MP0005334_abnormal_fat_pad | 0.36970318 |
| 145 | MP0003943_abnormal_hepatobiliary_system | 0.36440799 |
| 146 | MP0000678_abnormal_parathyroid_gland | 0.36027793 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.35502855 |
| 148 | MP0002069_abnormal_eating/drinking_beha | 0.34635905 |
| 149 | MP0009672_abnormal_birth_weight | 0.34432778 |
| 150 | MP0003795_abnormal_bone_structure | 0.34073963 |
| 151 | MP0004272_abnormal_basement_membrane | 0.33555010 |
| 152 | MP0000462_abnormal_digestive_system | 0.32734948 |
| 153 | MP0010678_abnormal_skin_adnexa | 0.32698546 |
| 154 | MP0006036_abnormal_mitochondrial_physio | 0.32663444 |
| 155 | MP0005381_digestive/alimentary_phenotyp | 0.31413824 |
| 156 | MP0002098_abnormal_vibrissa_morphology | 0.31400774 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.31164085 |
| 158 | MP0000371_diluted_coat_color | 0.30145164 |
| 159 | MP0001270_distended_abdomen | 0.29416173 |
| 160 | MP0001663_abnormal_digestive_system | 0.29355503 |
| 161 | MP0005379_endocrine/exocrine_gland_phen | 0.29339249 |
| 162 | MP0002796_impaired_skin_barrier | 0.28270493 |
| 163 | MP0005319_abnormal_enzyme/_coenzyme | 0.27974793 |
| 164 | MP0000377_abnormal_hair_follicle | 0.27688253 |
| 165 | MP0001756_abnormal_urination | 0.27117140 |
| 166 | MP0001849_ear_inflammation | 0.26518936 |
| 167 | MP0000579_abnormal_nail_morphology | 0.26418745 |
| 168 | MP0000367_abnormal_coat/_hair | 0.25061444 |
| 169 | MP0001485_abnormal_pinna_reflex | 0.24987296 |
| 170 | MP0004130_abnormal_muscle_cell | 0.24953950 |
| 171 | MP0003329_amyloid_beta_deposits | 0.23725273 |
| 172 | MP0001873_stomach_inflammation | 0.23066885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 7.78267042 |
| 2 | Fat malabsorption (HP:0002630) | 6.85548990 |
| 3 | Gout (HP:0001997) | 6.47793548 |
| 4 | Abnormal pancreas size (HP:0012094) | 5.65459663 |
| 5 | Exocrine pancreatic insufficiency (HP:0001738) | 5.37778712 |
| 6 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.79714955 |
| 7 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.79714955 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 4.16424157 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.14271950 |
| 10 | Ketoacidosis (HP:0001993) | 4.11561978 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.98838174 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.87983073 |
| 13 | Ketosis (HP:0001946) | 3.55889262 |
| 14 | Late onset (HP:0003584) | 3.49436081 |
| 15 | Pancreatitis (HP:0001733) | 3.49023564 |
| 16 | Ventricular fibrillation (HP:0001663) | 3.46736447 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.38167798 |
| 18 | Absent/shortened dynein arms (HP:0200106) | 3.38167798 |
| 19 | Hypoplasia of the pons (HP:0012110) | 3.35956883 |
| 20 | Tubulointerstitial fibrosis (HP:0005576) | 3.34500528 |
| 21 | Febrile seizures (HP:0002373) | 3.33604776 |
| 22 | Type I diabetes mellitus (HP:0100651) | 3.28699445 |
| 23 | Decreased subcutaneous fat (HP:0001002) | 3.26991938 |
| 24 | Hyperglycemia (HP:0003074) | 3.23081774 |
| 25 | Tubulointerstitial nephritis (HP:0001970) | 3.16589225 |
| 26 | Hyperventilation (HP:0002883) | 3.13347673 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09944308 |
| 28 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.08813953 |
| 29 | Carpal bone hypoplasia (HP:0001498) | 3.07961348 |
| 30 | Abnormality of the pons (HP:0007361) | 3.06197953 |
| 31 | Symptomatic seizures (HP:0011145) | 3.06187119 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 3.04396109 |
| 33 | Myositis (HP:0100614) | 3.03993330 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.01680299 |
| 35 | Short chin (HP:0000331) | 3.01450681 |
| 36 | Premature skin wrinkling (HP:0100678) | 2.99630444 |
| 37 | Hypoproteinemia (HP:0003075) | 2.98900317 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96716380 |
| 39 | Cortical dysplasia (HP:0002539) | 2.96413141 |
| 40 | Hyperuricemia (HP:0002149) | 2.91175054 |
| 41 | Increased purine levels (HP:0004368) | 2.91175054 |
| 42 | Stomatitis (HP:0010280) | 2.86975482 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.84809536 |
| 44 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.83942562 |
| 45 | Abnormal tarsal ossification (HP:0008369) | 2.82324653 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.80454679 |
| 47 | Optic neuritis (HP:0100653) | 2.78872985 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.78872985 |
| 49 | Focal motor seizures (HP:0011153) | 2.72347533 |
| 50 | Progressive cerebellar ataxia (HP:0002073) | 2.69756485 |
| 51 | Ankyloglossia (HP:0010296) | 2.68235163 |
| 52 | Large for gestational age (HP:0001520) | 2.67821683 |
| 53 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.66472337 |
| 54 | Small epiphyses (HP:0010585) | 2.63893014 |
| 55 | Broad-based gait (HP:0002136) | 2.59487857 |
| 56 | Orchitis (HP:0100796) | 2.58556188 |
| 57 | Genetic anticipation (HP:0003743) | 2.57861599 |
| 58 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.56836232 |
| 59 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.56836232 |
| 60 | Maternal diabetes (HP:0009800) | 2.56734552 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.56043265 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.52234809 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.51605893 |
| 64 | Absent speech (HP:0001344) | 2.51485863 |
| 65 | Hyperglycinemia (HP:0002154) | 2.50674068 |
| 66 | Unilateral renal agenesis (HP:0000122) | 2.49200985 |
| 67 | Thyroid-stimulating hormone excess (HP:0002925) | 2.47603011 |
| 68 | Congenital glaucoma (HP:0001087) | 2.45403741 |
| 69 | Pancreatic cysts (HP:0001737) | 2.40098104 |
| 70 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.37945159 |
| 71 | Long foot (HP:0001833) | 2.35891657 |
| 72 | Hypoplasia of the odontoid process (HP:0003311) | 2.35436504 |
| 73 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.33913740 |
| 74 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.33579349 |
| 75 | Exercise-induced myalgia (HP:0003738) | 2.32354789 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.31404764 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 2.29919568 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 2.29919568 |
| 79 | Focal seizures (HP:0007359) | 2.29555465 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.29489727 |
| 81 | Limb hypertonia (HP:0002509) | 2.29137509 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.28236769 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.28196196 |
| 84 | Calf muscle hypertrophy (HP:0008981) | 2.27186687 |
| 85 | Acute hepatic failure (HP:0006554) | 2.27060400 |
| 86 | Prolonged QT interval (HP:0001657) | 2.24978304 |
| 87 | Severe short stature (HP:0003510) | 2.23672699 |
| 88 | Nephronophthisis (HP:0000090) | 2.23491649 |
| 89 | Bundle branch block (HP:0011710) | 2.21328405 |
| 90 | Esophageal varix (HP:0002040) | 2.21301347 |
| 91 | Right ventricular cardiomyopathy (HP:0011663) | 2.21247734 |
| 92 | Insulin resistance (HP:0000855) | 2.21235390 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 2.21220407 |
| 94 | Abnormal foot bone ossification (HP:0010675) | 2.19977644 |
| 95 | Hyperglycinuria (HP:0003108) | 2.16422630 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.14774131 |
| 97 | Muscle fiber inclusion bodies (HP:0100299) | 2.14096533 |
| 98 | Decreased circulating renin level (HP:0003351) | 2.12702502 |
| 99 | Polydipsia (HP:0001959) | 2.11721254 |
| 100 | Abnormal drinking behavior (HP:0030082) | 2.11721254 |
| 101 | Enlarged penis (HP:0000040) | 2.11218483 |
| 102 | Protruding tongue (HP:0010808) | 2.11160508 |
| 103 | Metaphyseal dysplasia (HP:0100255) | 2.11152684 |
| 104 | Keratoconjunctivitis (HP:0001096) | 2.10095334 |
| 105 | Mucopolysacchariduria (HP:0008155) | 2.08617853 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08617853 |
| 107 | Joint stiffness (HP:0001387) | 2.06084778 |
| 108 | Muscle fiber splitting (HP:0003555) | 2.05299506 |
| 109 | Metabolic alkalosis (HP:0200114) | 2.05279221 |
| 110 | Gait imbalance (HP:0002141) | 2.04966581 |
| 111 | Barrel-shaped chest (HP:0001552) | 2.04660515 |
| 112 | Pancreatic fibrosis (HP:0100732) | 2.04235098 |
| 113 | Hypotension (HP:0002615) | 2.02876850 |
| 114 | Epiphyseal dysplasia (HP:0002656) | 2.02705723 |
| 115 | Widely spaced teeth (HP:0000687) | 2.02654390 |
| 116 | Hyperkalemia (HP:0002153) | 2.01608333 |
| 117 | Cortical visual impairment (HP:0100704) | 2.00981513 |
| 118 | True hermaphroditism (HP:0010459) | 2.00024746 |
| 119 | Type II lissencephaly (HP:0007260) | 1.99551480 |
| 120 | Intrahepatic cholestasis (HP:0001406) | 1.98902078 |
| 121 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.98486634 |
| 122 | Fatigue (HP:0012378) | 1.98469864 |
| 123 | Abolished electroretinogram (ERG) (HP:0000550) | 1.98301807 |
| 124 | Hypsarrhythmia (HP:0002521) | 1.97878531 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.97695230 |
| 126 | Abnormal EKG (HP:0003115) | 1.96924855 |
| 127 | Flattened epiphyses (HP:0003071) | 1.96631033 |
| 128 | Tubular atrophy (HP:0000092) | 1.96441991 |
| 129 | Papilledema (HP:0001085) | 1.96336255 |
| 130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94983955 |
| 131 | Keratoconjunctivitis sicca (HP:0001097) | 1.94775996 |
| 132 | Abnormality of macular pigmentation (HP:0008002) | 1.93531666 |
| 133 | Hypokalemic alkalosis (HP:0001949) | 1.93512289 |
| 134 | Macroorchidism (HP:0000053) | 1.93317600 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.92736767 |
| 136 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.92683002 |
| 137 | Chronic hepatic failure (HP:0100626) | 1.92605977 |
| 138 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.91935497 |
| 139 | Abnormality of glycine metabolism (HP:0010895) | 1.90356419 |
| 140 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.90356419 |
| 141 | Stomach cancer (HP:0012126) | 1.90331845 |
| 142 | Bronchiectasis (HP:0002110) | 1.90104102 |
| 143 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89198091 |
| 144 | Atonic seizures (HP:0010819) | 1.89166366 |
| 145 | Decreased central vision (HP:0007663) | 1.88773670 |
| 146 | Agitation (HP:0000713) | 1.88046157 |
| 147 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.88030258 |
| 148 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88007317 |
| 149 | Polyuria (HP:0000103) | 1.87869040 |
| 150 | Clumsiness (HP:0002312) | 1.87669624 |
| 151 | Myocardial infarction (HP:0001658) | 1.87428969 |
| 152 | Abnormality of oral frenula (HP:0000190) | 1.86743215 |
| 153 | Dialeptic seizures (HP:0011146) | 1.86653251 |
| 154 | Congenital primary aphakia (HP:0007707) | 1.86429497 |
| 155 | Potter facies (HP:0002009) | 1.86370146 |
| 156 | Facial shape deformation (HP:0011334) | 1.86370146 |
| 157 | Nemaline bodies (HP:0003798) | 1.85811916 |
| 158 | Abnormality of the odontoid process (HP:0003310) | 1.85432533 |
| 159 | Tubulointerstitial abnormality (HP:0001969) | 1.85404957 |
| 160 | Inability to walk (HP:0002540) | 1.84513998 |
| 161 | Abnormal number of erythroid precursors (HP:0012131) | 1.84006618 |
| 162 | Rectal prolapse (HP:0002035) | 1.83641769 |
| 163 | Abdominal distention (HP:0003270) | 1.83356046 |
| 164 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.82386327 |
| 165 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80833140 |
| 166 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80833140 |
| 167 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80833140 |
| 168 | Recurrent bacterial skin infections (HP:0005406) | 1.80746752 |
| 169 | Syncope (HP:0001279) | 1.80431261 |
| 170 | Hemoptysis (HP:0002105) | 1.79624317 |
| 171 | Epileptic encephalopathy (HP:0200134) | 1.79388394 |
| 172 | Renal salt wasting (HP:0000127) | 1.79229103 |
| 173 | Pectus carinatum (HP:0000768) | 1.79216059 |
| 174 | Epileptiform EEG discharges (HP:0011182) | 1.78929115 |
| 175 | Pigmentary retinal degeneration (HP:0001146) | 1.76948182 |
| 176 | Abnormality of chloride homeostasis (HP:0011422) | 1.75491878 |
| 177 | Cystic liver disease (HP:0006706) | 1.75448466 |
| 178 | Rhinitis (HP:0012384) | 1.73675611 |
| 179 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73529544 |
| 180 | Left ventricular hypertrophy (HP:0001712) | 1.69650992 |
| 181 | Recurrent abscess formation (HP:0002722) | 1.69510265 |
| 182 | Abnormality of binocular vision (HP:0011514) | 1.68965200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.91633881 |
| 2 | EIF2AK3 | 4.54378866 |
| 3 | TRIB3 | 4.05553732 |
| 4 | ERN1 | 3.97156384 |
| 5 | MAP2K2 | 3.94482883 |
| 6 | TAOK3 | 3.79445096 |
| 7 | INSRR | 3.75836619 |
| 8 | FRK | 3.43278097 |
| 9 | PKN2 | 3.29328127 |
| 10 | OBSCN | 2.85240151 |
| 11 | IRAK3 | 2.58637013 |
| 12 | ADRBK2 | 2.43180088 |
| 13 | PINK1 | 2.08680048 |
| 14 | LATS1 | 1.95583260 |
| 15 | TNK2 | 1.82491156 |
| 16 | RIPK4 | 1.79990732 |
| 17 | WNK4 | 1.77443437 |
| 18 | TXK | 1.73803985 |
| 19 | MAP2K1 | 1.68175510 |
| 20 | MAP3K2 | 1.66275351 |
| 21 | ZAP70 | 1.66086628 |
| 22 | PHKG1 | 1.64397492 |
| 23 | PHKG2 | 1.64397492 |
| 24 | FES | 1.57603866 |
| 25 | PASK | 1.52813595 |
| 26 | EPHA4 | 1.51007815 |
| 27 | PTK6 | 1.50682721 |
| 28 | MAP4K1 | 1.50629294 |
| 29 | SCYL2 | 1.47110927 |
| 30 | ACVR1B | 1.41544935 |
| 31 | CCNB1 | 1.40422022 |
| 32 | GRK1 | 1.35008314 |
| 33 | MAPK13 | 1.34757055 |
| 34 | MAPK15 | 1.33775052 |
| 35 | PDGFRB | 1.33151703 |
| 36 | DYRK1A | 1.31721275 |
| 37 | PAK2 | 1.27731038 |
| 38 | TEC | 1.27036856 |
| 39 | SIK1 | 1.27015923 |
| 40 | FLT3 | 1.26150286 |
| 41 | SGK2 | 1.25420954 |
| 42 | BLK | 1.24816788 |
| 43 | OXSR1 | 1.20534463 |
| 44 | SYK | 1.18390708 |
| 45 | MAPKAPK3 | 1.16017877 |
| 46 | IRAK2 | 1.14407596 |
| 47 | RET | 1.11162706 |
| 48 | CASK | 1.10614921 |
| 49 | MAPK12 | 1.10003307 |
| 50 | PDGFRA | 1.09894783 |
| 51 | KIT | 1.08590590 |
| 52 | HIPK2 | 1.07586039 |
| 53 | CAMKK1 | 1.07227065 |
| 54 | EEF2K | 1.05792334 |
| 55 | ITK | 1.03303940 |
| 56 | CAMK1 | 1.01718715 |
| 57 | BMPR1B | 1.01660646 |
| 58 | PRKD3 | 1.01583455 |
| 59 | CDK19 | 1.01225855 |
| 60 | LMTK2 | 1.00607955 |
| 61 | MAP3K1 | 0.95981415 |
| 62 | IKBKE | 0.95455319 |
| 63 | STK11 | 0.93966097 |
| 64 | MARK1 | 0.93168341 |
| 65 | PIK3CA | 0.92575814 |
| 66 | NLK | 0.91369472 |
| 67 | MAP4K2 | 0.91047671 |
| 68 | PRKCE | 0.85989757 |
| 69 | CSK | 0.85501895 |
| 70 | CAMKK2 | 0.85485520 |
| 71 | PRKCH | 0.85163949 |
| 72 | WNK3 | 0.84812855 |
| 73 | PRKAA2 | 0.84323759 |
| 74 | TYK2 | 0.83847608 |
| 75 | HCK | 0.82913401 |
| 76 | PTK2B | 0.81862222 |
| 77 | BTK | 0.81818955 |
| 78 | PRKCQ | 0.81377991 |
| 79 | SGK494 | 0.81012911 |
| 80 | SGK223 | 0.81012911 |
| 81 | TRPM7 | 0.77557060 |
| 82 | ADRBK1 | 0.77123037 |
| 83 | LRRK2 | 0.76970301 |
| 84 | MTOR | 0.76840522 |
| 85 | SIK2 | 0.76371691 |
| 86 | CAMK4 | 0.76344804 |
| 87 | DYRK1B | 0.75852341 |
| 88 | MAPK7 | 0.75559597 |
| 89 | SGK3 | 0.75439105 |
| 90 | IRAK4 | 0.71029938 |
| 91 | IRAK1 | 0.70851379 |
| 92 | STK38 | 0.70374354 |
| 93 | TBK1 | 0.69685709 |
| 94 | RIPK1 | 0.69195898 |
| 95 | IKBKB | 0.69097673 |
| 96 | NTRK1 | 0.68314387 |
| 97 | SGK1 | 0.68291882 |
| 98 | LCK | 0.67410758 |
| 99 | TNIK | 0.64180947 |
| 100 | PTK2 | 0.62969401 |
| 101 | KSR2 | 0.62636592 |
| 102 | MARK2 | 0.62491192 |
| 103 | CAMK2A | 0.61139708 |
| 104 | STK39 | 0.60986941 |
| 105 | MARK3 | 0.60817538 |
| 106 | LYN | 0.60123824 |
| 107 | FGFR4 | 0.59318306 |
| 108 | PDK2 | 0.58921714 |
| 109 | PRKCI | 0.58834644 |
| 110 | RPS6KB2 | 0.58619121 |
| 111 | MET | 0.58311883 |
| 112 | BMPR2 | 0.55893273 |
| 113 | FER | 0.55517784 |
| 114 | JAK2 | 0.54982236 |
| 115 | PRKCG | 0.54907495 |
| 116 | AKT3 | 0.53831087 |
| 117 | PIK3CG | 0.53246713 |
| 118 | DAPK2 | 0.53238988 |
| 119 | PRKG1 | 0.52733204 |
| 120 | PDPK1 | 0.52594817 |
| 121 | NTRK2 | 0.51156316 |
| 122 | RPS6KB1 | 0.49343609 |
| 123 | GRK5 | 0.49178022 |
| 124 | PRKACA | 0.49122890 |
| 125 | WNK1 | 0.49067836 |
| 126 | PRKCZ | 0.48687550 |
| 127 | FGFR3 | 0.48665863 |
| 128 | TGFBR2 | 0.48413525 |
| 129 | EPHB1 | 0.48208254 |
| 130 | MAP3K7 | 0.46488906 |
| 131 | UHMK1 | 0.45109524 |
| 132 | PRKD1 | 0.43554266 |
| 133 | EPHA3 | 0.42900049 |
| 134 | PKN1 | 0.42371008 |
| 135 | PRKD2 | 0.40953042 |
| 136 | NME1 | 0.40739978 |
| 137 | FGFR2 | 0.39129863 |
| 138 | PDK1 | 0.38650789 |
| 139 | NEK6 | 0.38330526 |
| 140 | NTRK3 | 0.37843463 |
| 141 | CDC42BPA | 0.37448437 |
| 142 | IGF1R | 0.33132369 |
| 143 | CAMK1D | 0.28525156 |
| 144 | MAPK3 | 0.27012182 |
| 145 | DDR2 | 0.26987107 |
| 146 | CSNK1A1L | 0.25747213 |
| 147 | ABL1 | 0.25595610 |
| 148 | ILK | 0.23530605 |
| 149 | CAMK1G | 0.23329606 |
| 150 | PRKAA1 | 0.23080703 |
| 151 | CSNK1G2 | 0.20912682 |
| 152 | PRKACB | 0.20749133 |
| 153 | MAPK1 | 0.20601909 |
| 154 | CSNK1E | 0.20453326 |
| 155 | GSK3A | 0.20050399 |
| 156 | NUAK1 | 0.19205729 |
| 157 | BRSK2 | 0.18182070 |
| 158 | AKT1 | 0.18179713 |
| 159 | MAP2K4 | 0.18130370 |
| 160 | MAP3K9 | 0.18064740 |
| 161 | PAK3 | 0.17662998 |
| 162 | JAK1 | 0.17586761 |
| 163 | MAP2K6 | 0.17498430 |
| 164 | MAP3K4 | 0.17335270 |
| 165 | CSNK1A1 | 0.17247401 |
| 166 | EGFR | 0.17131826 |
| 167 | RPS6KA3 | 0.16912419 |
| 168 | RPS6KA1 | 0.15666758 |
| 169 | FGFR1 | 0.13573862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Pancreatic secretion_Homo sapiens_hsa04972 | 7.78044717 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.10957578 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.36522351 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.20551838 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.41379480 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.97963191 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.60354406 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.06092083 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.96202218 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93649916 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.78535978 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60856478 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.51370301 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.49040101 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.42571704 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41956236 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.39209431 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37530906 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.36109297 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.32305197 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31798192 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30519400 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.29415919 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21034078 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.20980710 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19430166 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16720388 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.16562211 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11451524 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11345092 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08961926 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08758065 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.08350605 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05843204 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02033271 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98795873 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 0.97747555 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96869266 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96735901 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96720703 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95107326 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.94446455 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 0.93468203 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93373220 |
| 45 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91403271 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91091206 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88416846 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85833960 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85523941 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85254631 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83993634 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82293950 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81982536 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80743254 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79453824 |
| 56 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79057737 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77020972 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75247574 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.74926933 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74203881 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72508443 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72336332 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70165061 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69281669 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69037072 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68998666 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67942975 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66731012 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66482789 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66121029 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65905545 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64684365 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62770168 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60721293 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.60545635 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60269601 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60196298 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.60080856 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58932855 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57155249 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57066988 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56923247 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56770515 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.55970406 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55351696 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.53617422 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53153774 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53057241 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52474941 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51969140 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51766971 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51304021 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51207044 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50238937 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.50175769 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50133941 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49774423 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49410250 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49290186 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48048600 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46766781 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45723521 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44304148 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43290074 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42830478 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42552659 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41928148 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41854047 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40470216 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40257867 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.40152094 |
| 112 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39997242 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.36683484 |
| 114 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35713379 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34309213 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34040319 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.33927115 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33806358 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33465355 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32812071 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32599239 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31616142 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31198746 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30753940 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28644622 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28571392 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28401953 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27563767 |
| 129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27505160 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26113365 |
| 131 | Lysine degradation_Homo sapiens_hsa00310 | 0.25850612 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22795381 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22460811 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21574951 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21495666 |
| 136 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.20619493 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19829366 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18504922 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17856939 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16836981 |
| 141 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16113929 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15020629 |
| 143 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.14682514 |
| 144 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14519094 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.13773504 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.13480066 |
| 147 | Viral myocarditis_Homo sapiens_hsa05416 | 0.12962754 |
| 148 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12499424 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12126632 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11713300 |
| 151 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11563961 |
| 152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11491659 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.11241299 |
| 154 | Renin secretion_Homo sapiens_hsa04924 | 0.09596861 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09130432 |
| 156 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07322437 |
| 157 | GABAergic synapse_Homo sapiens_hsa04727 | 0.07036943 |
| 158 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.06239818 |
| 159 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.05804760 |

